(Q35989224)

11 August 2017

0 references

1 reference

title

Major bleeding rates after prophylaxis against venous thromboembolism: systematic review, meta-analysis, and cost implications (English)

1 reference

11 August 2017

main subject

venous thromboembolism

1 reference

1 reference

David A Scott

2

0 references

Matthias Egger

object named as

Matthias Egger

series ordinal

4

0 references

author name string

James Muntz

series ordinal

1

1 reference

11 August 2017

Adam Lloyd

series ordinal

3

1 reference

11 August 2017

publication date

1 January 2004

1 reference

International Journal of Technology Assessment in Health Care

11 August 2017

published in

1 reference

11 August 2017

volume

20

1 reference

11 August 2017

issue

4

1 reference

11 August 2017

page(s)

405-414

1 reference

Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Prophylaxis of postoperative thromboembolism with low molecular weight heparins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

A synthetic pentasaccharide for the prevention of deep-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Efficacy of a postoperative regimen of enoxaparin in deep vein thrombosis prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Prevention of deep vein thrombosis by low-molecular-weight heparin and dihydroergotamine in patients undergoing total hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Exploring heterogeneity in meta-analysis: is the L'Abbé plot useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Enoxaparin for thromboprophylaxis after major trauma: potential cost implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Low molecular weight heparin associated with spinal anaesthesia and gradual compression stockings in total hip replacement surgery. Arar Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Cost-effectiveness of prophylaxis in total hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Prevention of deep vein thrombosis in patients with hip fractures: low molecular weight heparin versus dextran

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Warfarin sodium in prevention of deep venous thrombosis and pulmonary embolism in patients with fractured neck of femur

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Low-molecular-weight heparin versus warfarin for secondary prophylaxis of venous thromboembolism: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Prolonged prophylaxis in orthopedic surgery: insights from the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Thromboembolic prophylaxis in total hip replacement: a comparison between the low molecular weight heparinoid Lomoparan and heparin-dihydroergotamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Hemorrhagic complications of anticoagulant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: outcome of therapy and health economy aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

Prevention of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Low-molecular-weight heparin (enoxaparin) vs dextran 70. The prevention of postoperative deep vein thrombosis after total hip replacement. The Danish Enoxaparin Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Prevention of venous thrombosis and pulmonary embolism in injured patients. A trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Combined administration of low dose heparin and aspirin as prophylaxis of deep vein thrombosis after hip joint surgery

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Systematic Reviews in Health Care

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Prevention of thromboembolism in total hip replacement. Aspirin versus dihydroergotamine-heparin

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Prolonged prophylaxis with unfractioned heparin is effective to reduce delayed deep vein thrombosis in total hip replacement

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Low-dose warfarin versus external pneumatic compression for prophylaxis against venous thromboembolism following total hip replacement

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Failure of low-dose heparin to prevent deep-vein thrombosis after hip-replacement arthroplasty

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Cost analyses of extended prophylaxis with enoxaparin after hip arthroplasty

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Thromboprophylaxis in hip fracture surgery: a pilot study comparing danaparoid, enoxaparin and dalteparin. The TIFDED Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

A pharmacoeconomic assessment of enoxaparin and warfarin as prophylaxis for deep vein thrombosis in patients undergoing knee replacement surgery

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Prevention of deep vein thrombosis after total hip replacement. The effect of low-molecular-weight heparin with spinal and general anaesthesia

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Prophylaxis for the prevention of venous thromboembolism after total knee arthroplasty. A comparison between unfractionated and low-molecular-weight heparin.

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgery. Reviparin Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Bleeding complications with enoxaparin for deep venous thrombosis prophylaxis

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Two-step warfarin therapy. Prevention of postoperative venous thrombosis without excessive bleeding

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Fixed low-dose versus adjusted higher-dose warfarin following orthopedic surgery. A randomized prospective trial

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge

1 reference

https://api.crossref.org/works/10.1017%2FS026646230400128X

7 January 2021

10.1017/S026646230400128X

Identifiers

DOI

1 reference

release_6f2ojc4nxfgt5ckkd5n2pefcki

11 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6f2ojc4nxfgt5ckkd5n2pefcki

24 November 2022

mapped directly with Wikidata item

1 reference